InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: KCSVEN post# 235502

Wednesday, 12/18/2019 9:43:47 AM

Wednesday, December 18, 2019 9:43:47 AM

Post# of 428756
K-

No way BP prices 50% more for Rest of the world where Amarin has to sell the rights to others and only collect a small percentage in residual.

My view: BP will price the BP GIA higher than Amarin GIA. Maybe the 50% is high … some DD required (e.g. what is the licensing revenue of other Co that has a GIA in the US only) but I do not think it worth the effort.

Europe accounted for less than 15% of overall sales for best selling statin without having to be a residual, no way Amarin gets more than 10-15% from a BP for ROW

Lipitor revenue (2007):
- US: 7.2 bn
- RoW: 5.5 bn (76% of US, 43% of total)
- Total: 12.7 bn

Best,
G

"There are some things money can't buy. … For these, there is AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News